These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

649 related articles for article (PubMed ID: 9182180)

  • 21. [Interest and limits of estimation of the carcinoembryonic antigen in colonic and rectal (author's transl)].
    Arnaud JP; Simon P; Ollier JC; Koehl C; Adloff M
    J Chir (Paris); 1979 Nov; 116(11):633-6. PubMed ID: 555768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carcinoembryonic antigen (CEA). Use and limitations of the CEA radioimmunoassay in the diagnosis and follow-up of colo-rectal carcinoma.
    Mach JP; Pusztaszeri G; MacDonald D; Bertholet MM
    Johns Hopkins Med J Suppl; 1974; 3():369-79. PubMed ID: 4421371
    [No Abstract]   [Full Text] [Related]  

  • 23. Preoperative CEA level: a prognostic test in patients with colorectal carcinoma.
    Kohler JP; Simonowitz D; Paloyan D
    Am Surg; 1980 Aug; 46(8):449-52. PubMed ID: 7406353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Value of carcinoembryonic antigen (CEA) in the diagnosis and postoperative monitoring of patients with colorectal cancer].
    Catania G; Basile F; Cardì F; Azzarello G; Mazzarino C; Campo M; Giovinetto A
    Minerva Chir; 1981 May; 36(9):569-80. PubMed ID: 6789243
    [No Abstract]   [Full Text] [Related]  

  • 25. [Carcinoembryonic antigen measurement used routinely in the control of patients subjected to surgical treatment for colorectal cancer].
    Werner C; Nielsen J; Sparsø BH
    Ugeskr Laeger; 1988 Feb; 150(7):426-8. PubMed ID: 3381354
    [No Abstract]   [Full Text] [Related]  

  • 26. Are carcinoembryonic antigen levels of value in the curative management of colorectal cancer?
    Wanebo HJ
    Surgery; 1981 Mar; 89(3):290-5. PubMed ID: 7466616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating immune complexes (CIC), carcinoembryonic antigen (CEA) and CIC containing CEA as markers for colorectal cancer.
    Chester KA; Begent RH
    Clin Exp Immunol; 1984 Dec; 58(3):685-93. PubMed ID: 6509799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Value of CEA in the early diagnosis of colorectal cancer recurrence in the light of second-look results].
    Colombo PL; Lovotti D; Franco F; Coronelli M; Bonacasa R
    Minerva Med; 1986 Mar; 77(13):495-8. PubMed ID: 3703341
    [No Abstract]   [Full Text] [Related]  

  • 29. [The value and limitations of carcinoembryonic antigen levels (CEA) in colorectal cancers (author's transl)].
    Grossetti D; de Certaines J; Trebuchet G; Auvray E; Bernard AM; Launois B
    Ann Chir; 1981 Dec; 35(10):875-7. PubMed ID: 7325563
    [No Abstract]   [Full Text] [Related]  

  • 30. [Significance of carcinoembryonic antigen in the treatment of colorectal cancers].
    Putzki H
    Zentralbl Chir; 1986; 111(18):1119-23. PubMed ID: 3788331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The carcinoembryonic antigen level as an indicator for second look operations].
    Halevy A; Adam Y; Eschar J; Zaidman J; Sherf S
    Harefuah; 1980 Aug; 99(3-4):59-61. PubMed ID: 7203206
    [No Abstract]   [Full Text] [Related]  

  • 32. [Patient monitoring after surgical treatment of cancer of the large intestine].
    Krasnodebski IW
    Pol Tyg Lek; 1992 Jan 20-27; 47(3-4):95-7. PubMed ID: 1437794
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical evaluation of tumor markers in patients with colorectal cancer].
    Naritaka Y; Ogawa K; Matsumoto N; Hosokawa T; Kikuchi T; Koyama N; Haga S; Kajiwara T; Sakakibara N
    Gan No Rinsho; 1987 Aug; 33(10):1274-80. PubMed ID: 2444727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical evaluation of CEA in colorectal carcinoma].
    Shimoyama T; Fukuda Y; Itoh S; Shimizu T; Kawaguchi A; Mori M; Ishii T; Miura T; Tomita M
    Gan No Rinsho; 1985 May; 31(6 Suppl):648-54. PubMed ID: 3897618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prognostic significance of preoperative CEA titers in colorectal cancer].
    Schneider K; Metzger U; Joller H; Grob PJ; Largiadèr F
    Helv Chir Acta; 1983 Mar; 49(6):843-7. PubMed ID: 6862990
    [No Abstract]   [Full Text] [Related]  

  • 36. The role of tumor markers in the management of colorectal cancer.
    Go VL; Zamcheck N
    Cancer; 1982 Dec; 50(11 Suppl):2618-23. PubMed ID: 7139557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Utility of CA19-9 and CEA as tumor marker in colorectal cancer--comparison between serum level and distribution].
    Okuda K; Kodaira S; Watanabe M; Takami H; Teramoto T; Abe O; Iri H; Ino Y; Hirohashi S
    Nihon Gan Chiryo Gakkai Shi; 1986 Jun; 21(5):969-77. PubMed ID: 3463631
    [No Abstract]   [Full Text] [Related]  

  • 38. Carcinoembryonic antigen and CA19-9: implications of quantitative marker measurement in tissues for prognosis of colorectal cancer.
    Gebauer G; Müller-Ruchholtz W
    Cancer Detect Prev; 2001; 25(4):344-51. PubMed ID: 11531011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A study of the reliability of carcinoembryonic antigen blood levels in following the course of colorectal cancer.
    Armitage NC; Davidson A; Tsikos D; Wood CB
    Clin Oncol; 1984 Jun; 10(2):141-7. PubMed ID: 6375928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CEA levels at recurrence and metastases; importance for detecting secondary disease.
    Rieger A; Wahren B
    Scand J Gastroenterol; 1975; 10(8):869-74. PubMed ID: 1202621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.